EP2345455
Lacosamide for the treatment of hyperexcitability disorders associated with sodium channel dysfunction
:
EP einkaleyfi: Þýðing ekki lögð inn:
29.6.2007:
16.3.2016:
11002768.7
:
28.6.2027
:
Lacosamide for the treatment of hyperexcitability disorders associated with sodium channel dysfunction
29.6.2007
16.3.2016
:
UCB Pharma GmbH:
Alfred-Nobel-Strasse 10, 40789, Monheim, DE
:
Beyreuther, Bettina:
Düsseldorf, DE
:
Heers, Cara:
Darmstadt, DE
:
Stöhr, Thomas:
Mol, BE
:
06013655:
30.6.2006:
EP
:
06021469:
12.10.2006:
EP
:
06021470:
12.10.2006:
EP
:
06024241:
22.11.2006:
EP
:
A61P 25/08, A61K 31/165, A61P 9/06